drugset / Trial / NCT05584683

A Pharmacokinetic Study of LP-001 in Children With a Bacterial Infection

NCT05584683

Phase 1 Completed 39 enrolled Kaizen Bioscience Co.
Non-randomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to determine the pharmacokinetic profiles of LP-001, an amoxicillin and clavulanate formulation compared to the pharmacokinetic profiles of Augmentin ES-600 for use in pediatric patients with a bacterial infection.

Timeline

Start
2023-08-09
Primary completion
2024-12-16
Completion
2024-12-16

Drugs

EvaluationDrugModalityDoseRoute
Subject Amoxicillin Other / unclassified Oral
Subject Clavulanate Unknown Oral